NY · State guide
Best GLP-1 telehealth providers serving New York: NexLife availability, Wegovy and Zepbound access, compounded options, pricing, and New York-specific notes.
| Provider | Status in NY | Starting price |
|---|---|---|
| NexLife (editor's pick) | Rolling out 2026 | $199/mo |
| Henry Meds | ✓ Available | $297/mo |
| Hims | ✓ Available | $199/mo |
| Ro | ✓ Available | $145/mo |
| Mochi Health | ✓ Available | $79 + Rx |
| ZappyHealth | ✓ Available | $169/mo |
All FDA-approved GLP-1 medications are legally available in New York with a prescription:
New York imposes strict telehealth and compounding regulations. Some compounded GLP-1 programs are limited or unavailable in NY. Verify availability with the provider before signing up.
Coverage for Wegovy and Zepbound varies by carrier and employer plan. Most commercial plans require prior authorization. State Medicaid coverage varies. See our insurance hub for carrier-specific details.
Most major GLP-1 telehealth providers serve New York, including NexLife (editor's pick, $rolling out 2026), Henry Meds, Hims, Ro, Mochi Health, and ZappyHealth. See our full provider rankings.
Yes, both Wegovy and Zepbound are FDA-approved and available in New York through telehealth or in-person prescribers, subject to insurance coverage and prior authorization.
Compounded semaglutide is available through Henry Meds, Hims, ZappyHealth, and others. NexLife is rolling out service in New York in 2026.
Compounded GLP-1 programs serving New York typically range $169–$499/month, depending on medication, dose, and provider. Brand-name Wegovy and Zepbound list prices range $1,086–$1,349/month, often reduced significantly with insurance prior auth.
State Medicaid coverage for weight-loss GLP-1s varies. Some state Medicaid programs cover Wegovy with criteria; many do not. Check New York Medicaid drug formulary directly.